Filing Flows › Starling Oncology (STLN) › Free cash flow
Starling Oncology (STLN) free cash flow by quarter
Starling Oncology's free cash flow was $8.9M in Q3 2026 (third quarter 2026), -20% from Q2 2026. Over the last 3 quarters it ranged from $2.2M (Q4 2025) to $11.0M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.9M | -20% | — |
| Q2 2026 | $11.0M | +408% | — |
| Q4 2025 | $2.2M | — | — |
Q3 2026 at a glance
Starling Oncology, Q3 2026: revenue $170M (+24% year over year), operating margin -1.8%, net loss $15.7M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Starling Oncology's free cash flow?
Starling Oncology's free cash flow was $8.9M in Q3 2026 (third quarter 2026), -20% from Q2 2026.
How has Starling Oncology's free cash flow changed?
Over the last 3 quarters it ranged from $2.2M (Q4 2025) to $11.0M (Q2 2026).